Idiopathic Restrictive Cardiomyopathy in Children and Young Adults

Heather N Anderson1, Frank Cetta2, David J Driscoll2

  • 1Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota.

Insights

Idiopathic restrictive cardiomyopathy (IRC) in children has a poor prognosis, but early cardiac transplantation improved overall survival in a contemporary cohort. An elevated mitral valve Doppler E/e

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Rare Diseases

Background:

  • Idiopathic restrictive cardiomyopathy (IRC) is a rare pediatric condition.
  • IRC is characterized by reduced ventricular compliance and poor patient outcomes.
  • Most children with IRC progress to cardiac transplantation.

Purpose of the Study:

  • To analyze institutional experience and contemporary outcomes for pediatric IRC.
  • To compare outcomes between historical and contemporary cohorts.
  • To identify factors associated with mortality in pediatric IRC.

Main Methods:

  • Retrospective review of patients (<21 years) diagnosed with IRC (1975-2013).
  • Division into historical (1975-1993) and contemporary (1994-2013) cohorts.
  • Analysis of demographic, clinical, echocardiographic, and catheterization data.

Main Results:

  • Overall survival improved significantly in the contemporary cohort (80% vs. 38%, p=0.02).
  • Cardiac transplantation occurred in 58% of the contemporary cohort.
  • Elevated mitral valve Doppler E/e' ratio was associated with increased mortality (p=0.01).

Conclusions:

  • IRC remains a condition with a poor prognosis in children.
  • Early referral for cardiac transplantation is linked to improved overall survival.
  • Markedly elevated E/e' ratio may indicate a higher risk of death.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
593
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
36.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
620